Medication Risk Mitigation: Coordinating and Collaborating with Health Care Systems, Universities, and Researchers to Facilitate the Design and Execution of Practice-Based Research

• Autores: Kevin T. Bain, Calvin H. Knowlton, Jacques Turgeon
• Localización: Clinics in geriatric medicine, ISSN 0749-0690, Vol. 33, Nº. 2, 2017, págs. 257-281
• Idioma: inglés
• Enlaces
  • Texto Completo Ejemplar
• Resumen

  • The high prevalence of inappropriate polypharmacy in geriatric populations is unacceptable. Traditional medication risk mitigation (MRM) strategies have proven to be effective at improving polypharmacy, but these strategies have not consistently translated into positive health outcomes. Enhanced MRM strategies, such as using pharmacogenomics information, are needed, and these strategies need to be tested. A formidable challenge is successfully integrating pharmacogenomic information into clinical practice. As the medication experts on health care teams, pharmacists have a clear role to play in developing, integrating, and assessing enhanced MRM strategies to improve therapeutic outcomes for geriatric patients.